Karin has 20+ years of experience in different leadership positions within the MedTech industry. She has a broad background in product development, product management, and business operations.
Before joining PeptiSystems, Karin had the overall business responsibility as General Manager for a subdivision within GE Healthcare's Molecular Imaging segment.
She has a PhD position in Solid State electronics from Uppsala University.

Lars invented the first large-scale flowthrough column technology instruments for oligonucleotide synthesis while at Pharmacia in the 1990s. He worked for GE Healthcare commercializing the instruments for many years until starting PeptiSystems in 2014.
He has a Ph.D. in Carbohydrate Chemistry 

Jonas has 20 years of experience in the Operation/Supply Chain industry, both as a manager and team leader.
Before joining PeptiSystems, Jonas had the overall Supply Chain responsibility as Supply Chain manager at Gyros Protein Technologies.

Jonas was trained in Logistics at Stockholm School TUC.

Ida Norberg holds a Master’s degree in Business and Economics from Uppsala University and brings more than 15 years of finance experience within the Life Science industry. Throughout her career, she has held key finance roles at leading organizations including GE Healthcare, C-RAD, and Oncopeptides.

Ida has developed extensive expertise in financial management, business partnering, and strategic finance, supporting growth and operational excellence in international organizations. Prior to joining PeptiSystems as Chief Financial Officer, she served as Business Controller at Oncopeptides.

At PeptiSystems, Ida is responsible for leading the company’s financial strategy and operations, supporting the organization’s continued growth and global expansion.

Florence has a M.Sc. in Science and Technology of agro-industry from Polytech'Montpellier, France. She has 20 years of experience developing and managing businesses with cutting-edge technologies in the Life Sciences market. She previously worked for companies like Biacore, and GE Healthcare. Before joining PeptiSystems, she was Senior Director, Head of Sales EMEA at Gyros Protein Technologies.

Mårten has over 30 years of experience in product development and quality assurance (QA) in the life science and diagnostic industry. Before joining PeptiSystems, Mårten held various positions, including line manager and project manager for Hardware, Software, Systems, Service, and QA teams.
Mårten brings a comprehensive knowledge of building quality management systems and developing and commercializing systems, including instruments, software, and consumables for end users in regulated environments. 

Mårten has a M.Sc. in engineering physics from Uppsala University.

Łukasz completed his Ph.D. in Peptide Chemistry in 2006 at the Faculty of Chemistry, University of Warsaw, Poland. He held multiple PostDoc positions in Brussels, Belgium, and Dublin, Ireland, working with companies on different projects related to the synthesis of peptide therapeutics. He then moved to the industry and worked as the Head of Peptide Libraries and R&D Manager for GENEPEP and later as the Product Manager for Gyros Protein Technologies. His goal is to combine his knowledge of Peptide Synthesis and interest in technology and apply it to the creation of better peptide synthesizers.

Alexander brings more than nine years of commercial experience across the life sciences, bioprocessing, and analytical instrumentation sectors. Prior to joining PeptiSystems, he held business development and sales leadership roles at Excellos, Gyros Protein Technologies, and Agilent Technologies, where he built a strong track record in strategic account development, revenue growth, and commercial expansion across the North American market.

He has extensive experience supporting customers in cell and gene therapy, GMP manufacturing, and advanced bioprocessing applications. Alexander holds a B.S. in Chemistry from the University of Delaware.

Rannar has over 30 years of experience in R&D of peptide chemistry, synthesis, biochemistry, and pharmacology. He was head of the R&D of the PeptiPilot Instruments at GEHC. He has a publication record of over 80 research articles in peer-reviewed scientific journals, book chapters, and several patents/patent applications. Rannar has a Ph.D. in Biological Chemistry and the qualification of Associate Professor in Medical Biochemistry at Karolinska Institute. He has previously co-founded companies in Life Sciences.

25+ years of experience from positions as Senior Researcher and Project Manager at GE Healthcare, SME, and RISE in MedTech, business development, design, and manufacturing of tailormade (bio)molecules and conjugates (small molecules, proteins/antibodies, lipids, carbohydrates, peptides, and oligonucleotides) for various life science and therapeutic applications in academic and industrial settings. Ulf has 8 patents/patent applications, and published over 20 scientific publications in peer-reviewed journals. Ulf has a Ph.D. in carbohydrate chemistry.

Martin has more than 20 years of experience in various R&D positions, mainly working with overall systems design. His experience includes most areas involved in product development, covering both hardware and software.
Before joining PeptiSystems, he was a Senior Engineer at GE HealthCare’s cyclotron group. He has a Ph. D. in Physics from Uppsala University.

Victoriia completed her Ph.D. in 2010 in the field of peptide chemistry and antibiotic modification. She did research in Germany, USA, Russia, and Sweden, mostly specializing in the field of in situ and in vitro peptide synthesis. She has wide experience in the life sciences areas.

Jie completed his Ph.D. in 2017 and worked as a Researcher at Uppsala University (2017-2019) and Postdoc. at Gothenburg University & Astrazeneca (2019-2021). He is an experienced organic chemist with expertise in peptide chemistry. 

Aleksandra brings a solid expertise in synthetic organic chemistry and biochemistry, with a PhD in peptide conjugation chemistry from Uppsala University. Her academic journey continued with postdoctoral research at Stockholm University, followed by impactful roles at Octapharma and Qiagen DNA Synthesis, where she contributed across QC, Production, and R&D.